PATENT CLAIM ANALYSIS

Application Number: 15878396
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "468000"]

Abstract:
The present invention relates to immediate release pharmaceutical compositions comprising one or more natural or synthetic cannabinoids, and one or more pharmaceutically acceptable excipients. More specifically, the invention relates to immediate release pharmaceutical compositions comprising cannabinoids and a process for preparation thereof.

Claim (Index 16):
A method for manufacture of a monolithic matrix drug composition comprising:\n a. mixing a cannabidiol , dibasic calcium phosphate, lactose monohydrate, pregelatinized modified starch, and hydroxyl ethyl cellulose; b. granulating the mixture with the solution to form a resulting mixture; c. drying the resulting mixture and sizing the granules; d. adding carbomer homopolymer, polyethylene oxide, hypromellose, and methacrylic acid copolymer to the granules; and e. adding a lubricant to the dried mixture.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.53333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15789998', '12876292', '15103850', '15554209', '14816959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7253895618156597
- 35 USC 102 Novelty (BERT): 0.5032673366394751
- Combined Prediction Score: 0.7031773392980413
- Mean Citation Score: 241.345694
- Max Citation Score: 257.61188
- Similarity Product: 179.96295928079846

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test